CoreCivic Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
5analysts covering
FY Revenue (est.)
$2.7Bnext fiscal year
FY EPS (est.)
$1.69next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 4 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Safety and Community Segment Occupancy Rate Quarterly7,960.0%Target: Stabilized occupancy across newly activated facilities
Average Daily Population (ADP) Quarterly57.2KTarget: Growth driven by full activation of California City, Diamondback, and Midwest Regional facilities
Federal Revenue Share Quarterly5,800.0%Target: Maintain strong federal partnerships while diversifying via commercial acquisitions
Watch Items
- Midwest Regional Reception Center Intake and OccupancyTrigger: Stabilized occupancy expected in Q3 2026Action: Monitor intake ramp-up following the Special Use Permit (SUP) approval in March 2026
- Clinical Solutions Pharmacy (CSP) IntegrationTrigger: Expected 2026 EPS contribution of $0.03 to $0.05Action: Track post-acquisition performance and expansion of mail-order pharmacy services across correctional facilities
- Federal Immigration Policy and ICE Detainee PopulationsTrigger: Fluctuations in ICE detainee counts (e.g., recent downturn due to enforcement redeployments)Action: Assess H2 2026 demand recovery and potential new contract awards from federal partners
Research as of 20 Jun 2026